D2.104 - Mental Health Care and Support in Patients with Atopic Dermatitis in Kazakhstan: One-Year Follow-Up Study

Atopic dermatitis (AD) is a chronic inflammatory skin disease that impacts physical, social, economic, and psychological well-being. Kazakhstan has seen a steady rise in AD cases in recent years. International evidence links AD with anxiety, depression, sleep issues, and social isolation. However, mental health care integration in dermatology and allergology in Kazakhstan is not well established.

In 2025, our team launched a study to evaluate the mental health burden in AD patients and access to psychological support. This poster shows baseline data and one-year follow-up results.

Study Design. Cross-sectional survey with 12-month follow-up. Over 250 participants: 42% adults (≥18 years) with AD. 58% parents of children/adolescents (7–17 years) with AD. Recruited from university clinics in Almaty.

Methods:

Structured questionnaire on psychological symptoms and AD–mental health links; Hospital Anxiety and Depression Scale (HADS) for adults.

Follow-Up Interventions.

Educational seminars for physicians

Distribution of informational materials

Routine HADS screening recommended

Referral pathways to mental health specialists established

Follow-up survey conducted after 12 months to assess impact

-52% of patients discussed mental health with their doctor (up from 35%)

-38% of adults screened with HADS Referrals to specialists increased by 27%

-Untreated anxiety/depression dropped by 15%

-Awareness of AD’s impact on mental health improved

-Parents reported better communication with providers Patients receiving psychological support showed: Better treatment adherence; Reduced stress during flare-ups; Improved quality of life

Patients with atopic dermatitis in Kazakhstan experience a significant mental health burden associated with disease severity. The implementation of structured screening and physician education improved detection and reduced untreated anxiety and depression within one year.

Nationwide screening, multidisciplinary management, provider training, and expanded access to psychological services are essential to improve long-term outcomes and quality of life.